Contact Us

Regulatory Challenges and FDA Approval of Biosimilars – An Overview

biosimilar biotech patent attorney

Biosimilars are generic versions of biologics, medicinal products with active drug component being made (or derived) from a living organism. It is complicated and cost intensive to manufacture biologics, and hence regulatory approval of biosimilars is very challenging.

Originally published here.

//storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges/embed//storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges.js[View the story “FDA Approval of Biosimilars – Regulatory Challenges” on Storify]

About the Author

Rahul Dev

Advice for Contacting

Engagements: Contractual Consulting, Hourly, Project Based

Contact Mode: LinkedIn or directly message here

Schedule a Consultation Now

Ask a General Question

Previous Blog Posts on Web

http://l.yimg.com/rt/pps/listbadge_1.8.js

Previous Blog Posts on Twitter


This is not a legal advice: Disclaimer, Non-Solicitation & Liability
Visit Technology Law Business Blog’s profile on Pinterest.//assets.pinterest.com/js/pinit.js

Read Our Blogs

Share with Friends

Share on facebook
Share on twitter
Share on linkedin
Share on email
US: 425-270-4712
+91 9650247494
rd (at) patentbusinesslawyer (dot) com
Level18,One Horizon Center,
Golf Course Road
DLF Phase 5,Sector 43

Disclaimer
The Bar Council of India restricts any form of advertisements. This blog contains general information for the convenience of readers and does not purport to dispense legal advice and is not intended to solicit or advertise in any manner.
Gurgaon,Haryana 122002
India

No Attorney-Client Relationship
The use of our blog, and the sending or receipt of information via this platform does not create an attorney-client relationship between you and us.
Copyright © 2020 by Rahul Dev. All Rights Reserved
Website by Seahawk